Cargando…

Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma

Most upper tract urothelial carcinomas (UTUC) are muscle invasive at the time of diagnosis. Current standard methods for the diagnosis of UTUC are invasive. Urine cytology is the only non‐invasive test for detecting UTUC, but its sensitivity is low. A novel non‐invasive assay for UTUC detection woul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Yujiro, Fujita, Kazutoshi, Matsuzaki, Kyosuke, Matsushita, Makoto, Kawamura, Norihiko, Koh, Yoko, Nakano, Kosuke, Wang, Cong, Ishizuya, Yu, Yamamoto, Yoshiyuki, Jingushi, Kentaro, Kato, Taigo, Kawashima, Atsunari, Ujike, Takeshi, Nagahara, Akira, Uemura, Motohide, Imamura, Ryoichi, Takao, Tetsuya, Takada, Shingo, Netto, George J, Nonomura, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501003/ https://www.ncbi.nlm.nih.gov/pubmed/30887605 http://dx.doi.org/10.1111/cas.14000

Ejemplares similares

STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma
por: Matsuzaki, Kyosuke, et al.
Publicado: (2018)

Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2018)

Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer
por: Matsuzaki, Kyosuke, et al.
Publicado: (2021)

MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma
por: Wang, Cong, et al.
Publicado: (2020)

Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers
por: Ujike, Takeshi, et al.
Publicado: (2022)

TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020)

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2019)

Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma
por: Kinouchi, Toshiro, et al.
Publicado: (2017)

MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma
por: Matsuzaki, Kyosuke, et al.
Publicado: (2017)

Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers
por: Tomiyama, Eisuke, et al.
Publicado: (2021)

Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2017)

Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer
por: Koh, Yoko, et al.
Publicado: (2020)

Diagnostic and prognostic significance of tartrate‐resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real‐world multi‐institutional study
por: Yamamichi, Gaku, et al.
Publicado: (2022)

R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy
por: Nagahara, Akira, et al.
Publicado: (2015)

Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution
por: Ujike, Takeshi, et al.
Publicado: (2016)

A novel model to predict positive prostate biopsy based on serum androgen level
por: Ujike, Takeshi, et al.
Publicado: (2017)

Fragmentation of cell‐free DNA is induced by upper‐tract urothelial carcinoma–associated systemic inflammation
por: Nakano, Kosuke, et al.
Publicado: (2020)

Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma
por: Kato, Taigo, et al.
Publicado: (2021)

Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma
por: Kawashima, Atsunari, et al.
Publicado: (2018)

Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma
por: Nakano, Kosuke, et al.
Publicado: (2022)

Selective arterial embolization for uncontrollable urethral hemorrhage in a patient with a left ventricular assist device
por: Hayashi, Yujiro, et al.
Publicado: (2018)

Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2020)

Seronegative rheumatoid arthritis after combination therapy with ipilimumab and nivolumab for postoperative pancreatic and liver metastases from renal cell carcinoma
por: Nishimura, Yuki, et al.
Publicado: (2022)

Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer
por: Hayashi, Takuji, et al.
Publicado: (2016)

Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report
por: Yamamoto, Tetsuya, et al.
Publicado: (2021)

Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2016)

FAN score comprising fibrosis-4 index, albumin–bilirubin score and neutrophil–lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab
por: Kawashima, Atsunari, et al.
Publicado: (2021)

A case of perirenal non‐specific lymphadenitis mimicking a solitary renal mass
por: Umeda, Shun, et al.
Publicado: (2021)

Mucinous cystadenoma of the renal parenchyma presenting as a Bosniak IIF complex renal cyst
por: Nate, Takanori, et al.
Publicado: (2023)

Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinoma
por: Kawashima, Atsunari, et al.
Publicado: (2020)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma
por: Koh, Yoko, et al.
Publicado: (2022)

Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2020)

Durable response of chemotherapy for cancer of unknown primary with unfavorable subset developed in retroperitoneal space
por: Matsukawa, Atsuki, et al.
Publicado: (2021)

A case of mediastinal teratoma with malignant transformation into angiosarcoma and relapse with multiple bone metastases that was cured by a multidisciplinary treatment
por: Tani, Masaru, et al.
Publicado: (2022)

Resumption of anti‐programmed cell death 1 monotherapy for severe immune‐related adverse events experienced patient with renal cell carcinoma
por: Maegawa, Yoko, et al.
Publicado: (2020)

Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study
por: Yamamoto, Akinaru, et al.
Publicado: (2022)

Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma
por: Yoshioka, Fumie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jssc601sj6sq25svk7hc7bsugm